Sophia Genetics (NASDAQ: SOPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 9.09 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $23.310 million which beat the analyst consensus estimate of $21.729 million by 7.28 percent. This is a 27.22 percent increase over sales of $18.323 million the same period last year.